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Abstract Despite recent advances, the prognosis of oral
squamous cell carcinoma is still poor. Therapeutic options
such as radiotherapy, chemotherapy, surgery and the novel
treatment option gene therapy are being investigated in
animal models. Diverse models have been studied to
induce oral squamous cell carcinomas. The carcinogenic
4-nitroquinoline-1-oxide (4NQO) model has proven to be
successful although until now it is unknown at what time
point the established tumor is a representative squamous
cell carcinoma and has a suitable volume for scientific
treatment. For this end we applied 4NQO 3 times a week
during 16 weeks and measured the volume of tumor tissue
each week until the end of the experiment at 40 weeks.
Concurrent histopathology at different time points up to
the end of the experiment revealed that all mice bearing
oral tumors were diagnosed with squamous cell carci-
noma. Immunohistochemistry with markers cyclin D1 and
E-cadherin revealed that the generated mouse oral tumors
showed strong similarities with the described immunopa-
thology in human oral tumors. The 4NQO model is a
suitable alternative for preclinical gene therapy experi-
ments with primary oral tumors. Future survey of thera-
peutic options in the carcinogenic 4NQO model should be
conducted around 40 weeks after the start of the treatment.
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Introduction
Oral cancer accounts for almost 275,000 new cases world-
wide each year (Parkin et al. 2005). The main risk factors for
developing oral cancer are tobacco smoking and consump-
tion of alcohol (Boffetta and Hashibe 2006). Continuation of
smoking during treatment can lead to increased morbidity
and mortality (Videtic et al. 2003). Primary treatment is
associated with high morbidity and function loss of the
organ, while up to 50% die due to recurrence (Monnerat et al.
2002). Present-day treatment, surgery, radiotherapy or che-
motherapy or a combination of these three, has had not-
withstanding the improvements, no significant improvement
in survival (Cooper et al. 2004). For that reason new treat-
ments, such as (targeted) gene therapy are being developed
(Ganesh et al. 2008; Ghobrial et al. 2005; Loeffler-Ragg
et al. 2008; Schoop et al. 2004; 2008).
New therapies can be investigated both in vitro and
in vivo. The drawback of in vitro laboratory study is the
dissimilarity between the cell culture and the physiological
processes giving misleading results. Several animal models
for oral squamous cell carcinoma are used including
hamster, rat and mouse models, with each model having its
own advantages and disadvantages. Earlier experiments
were set to induce tumors by mechanical damaging the jaw
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in mice (Eulderink 1972). Nowadays xenograft models are
widely used. In this model human cells are injected and
grow in immunodeficient mice. Advantages are the speed
and certainty of tumor development. The premier limita-
tion is the lack of functional T lymphocytes in nude mice
resulting in a non physiological tumor response.
The widely used hamster cheek pouch model in which
7,12-dimethlbenz(a)anthrance is used to induce tumors has
a disadvantage because the tumors are unalike the human
counterparts (Kanojia and Vaidya 2006). After the intro-
duction of 4-nitroquinoline-1-oxide (4-NQO) for inducing
tumors in rats (Wallenius and Lekholm 1973), it has been
extensively used in both rats and mouse and can useful for
analyzing the effects of anti-tumor agents (Suzuki et al.
2006). The 4NQO oral squamous cell carcinoma model is a
lengthy multi-step process in which eventual invasive
squamous cell carcinoma is attained after several months.
Once established the tumors are suitable for studying the
therapeutic effect of various therapies including gene
therapy. Intratumoral injection of recombinant adeno-viral
vectors is mainly used in preclinical models (St George
2003). Therefore at the time of injection a minimum tumor
volume must be attained and the realization of squamous
cell carcinoma must be assured. Up till now, in the 4NQO
mouse model, this time point is unknown.
The present study was set up to investigate the time
needed for sufficient tumor volume to be developed
enabling intra-tumoral injection of anticancer agents such
as gene therapy. As important, we have identified that the
generated mouse oral tumors resembles human oral tumor
formation.
Materials and methods
Animals and treatment with carcinogen
Thirty-two 7- and 8-weeks-old male CBA mice weighing
between 23 and 27 g were purchased from Harlan in Zeist,
The Netherlands. The experiments were approved in
advance by the Leiden University Animal Welfare Com-
mittee. All animals were kept at standard laboratory con-
ditions of alternating 12-h periods of light and darkness and
were fed sterilized laboratory chow and water ad libitum.
The carcinogen 4-nitroquinoline-1-oxide (Fig. 1) was
dissolved in propylene glycol to a final concentration of
5 mg/ml. For each session a fresh aliquot was used.
Anesthesia was achieved by inhalation of halothane vapour
and the tongue was stroked once with a no 3 camel hair
brush (Hawkins et al. 1994), which had been dipped in the
4NQO solution. The mice were restrained from drinking
the first hour after 4NQO application. The mice were
treated with 4NQO during 16 weeks with a frequency of 3
weekly treatments. All mice were carefully inspected daily
and weighed weekly.
Pathological examination and immunohistochemistry
After the final 4NQO application the oral mucosa of each
individual mouse was examined under inhalation anesthe-
sia every week. The volume of exophytic tumors was
calculated each week by measuring three dimensions
(length, height and width). After 24 weeks following the
start of the experiment 6 mice were sacrificed and tongue
tissue was removed and fixed in freshly made 4% buffered
formalin. Subsequently there were groups of 6 mice sac-
rificed after 28, 32, 36 and 40 weeks.
After paraffin-embedding, serial sections of 4 lm width
were made and one in five subsequent sections were
stained with hematoxylin-eosin (HE). The epithelia was
examined by a pathologist in our institution and classified
as either normal epithelia, mild dysplasia, moderate dys-
plasia, sever dysplasia or invasive squamous cell carci-
noma. Dysplastic epithelia and invasive squamous cell
carcinoma were subsequently investigated by immunohis-
tochemistry with cyclin D1 and E-cadherin. The following
antibodies were used from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA): the rabbit polyclonal antibody against
cyclin D1 (H-295, dilution 1:100) and a rabbit polyclonal
antibody against E-cadherin (H-108, dilution 1:50). After
the slides were deparaffinized and rehydrated, antibodies
were applied according to the manufacture’s protocol.
Results
Histological findings
The first macroscopic changes were seen 19 weeks after
starting the experiment. After 24 weeks some tongues did
not show any pathological changes (Fig. 2a) although at
the same phase hyperplasia without atypia and mild dys-
plastic changes were detected (Fig. 2b). Four weeks further
on, advance in atypia was found and moderate (Fig. 2c)
Fig. 1 Chemical structure of
4-nitroquinoline 1-oxide (4NQO)
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and severe dysplasia (Fig. 2d) could be detected. The first
evidence of squamous cell carcinoma was identified after
32 weeks (Fig. 2e). At the time point of 36 weeks 4 out of
6 animals that were sacrificed showed squamous cell car-
cinoma at histopathological examination. At 40 weeks, the
end of our experiment, all 6 tumors were squamous cell
carcinomas (data not shown).
Immunohistological findings
Once all 6 mice bearing tumors at the 40 weeks time point
were diagnosed with squamous cell carcinoma, immuno-
histochemistry was performed. A comparison of Cyclin D1
and E-cadherin expression was made in squamous cell
carcinoma detected after 40 weeks and mild dysplasia
established after 24 weeks. Immunohistological evaluation
was done in the tumors of our interest. Cyclin D1 expres-
sion was investigated by assessing the nuclear staining of
the antigen. Only nuclear staining was considered positive,
while cytoplasmatic staining was regarded as negative.
Mild dysplasia exposed predominantly basal cells
expressing cyclin D1 (Fig. 3c). The stainability increased
with the progression from dysplasia to carcinoma and the
positive ratio was the highest in the squamous cell carci-
noma (Fig. 3d). After 40 weeks, squamous cell carcinoma
showed a distribution throughout the tumor (Fig. 3d) as
well as the basal cell layer and lower spinous cells.
Staining of the tongue after 24 weeks showed that
E-cadherin was strongly expressed in the parabasal cell
layer, but not on the surface of basal cells (Fig. 3e). In the
oral squamous carcinoma we noticed a loss of E-cadherin
expression in the invasive front and positive staining of
cancer cell nests (Fig. 3f).
Tumor volume
The initial measurement of a volume of exophytic tumor
was done after 20 weeks following the start of the exper-
imental procedure. By measuring the size of the tumor in
three dimensions the volume was calibrated in mm3 by
using the following formula: V = l 9 w 9 h. The volumes
and ranges of each time point are shown in Fig. 4. After
20 weeks, the average volume was 6 mm3 with a range of
2–12 mm3. Gradually with time the volume increased and
reached 30 mm3 at the 40 weeks time point.
Fig. 2 Histological findings of tongue in mice treated with 4NQO
during 16 weeks. a Normal tongue with no histopathological changes
24 weeks after starting the experiment. b Mild dysplasia after
24 weeks. c Moderate dysplasia after 28 weeks. d Severe dysplasia
after 28 weeks. e Invasive squamous cell carcinoma after 32 weeks.
Original magnification 910
Fig. 3 Histopathology and immunohistochemistry staining with
biomarkers cyclin D1 and E-cadherin. The left panel shows mild
dysplasia after 24 weeks, the right panel shows squamous cell
carcinoma after 40 weeks. Hematoxylin-eosin staining (HE) of mild
dysplasia (a) and of squamous cell carcinoma (b) are shown. Cyclin
D1 is primarily expressed in basal cells in mild dysplasia (c) and
throughout the tumor and in tumor nests in squamous cell carcinoma
(d). E-cadherin is expressed in the parabasal cell layer of the
epithelium, but not on the surface of basal cells in mild dysplasia (e)
and is partly lost in the invasive front of squamous cell carcinoma (f).
Original magnification 94
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Discussion
Oral squamous cell carcinoma is one of the most common
cancers in the world. Novel treatment is best studied in
animal models that mimic the same clinical features as
human squamous cell carcinomas.
In this study we induced oral squamous cell carcinomas
by applying 4NQO oraly during 16 weeks in mice. Pre-
malignant laesions appeared 3 weeks after the last appli-
cation of 4NQO. The typical tumor progression for
squamous cell carcinoma was seen before invasive squa-
mous cell carcinomas appeared. At 36 weeks two-thirds of
the tumors were squamous cell carcinomas, 4 weeks fur-
ther all 6 oral tumors were squamous cell carcinomas.
These results are in accordance with earlier observed
results in which squamous cell carcinomas were detected
between 12 and 33 weeks after applying 4NQO during
16 weeks (Hawkins et al. 1994; Tang et al. 2004).
Immunohishtochemistry was performed on the tissues to
assess the similarities with human squamous cell carci-
noma. Biomarkers have been studied to predict behaviour
of tumor cells and are used to characterise tumors (Takes
2004). Cyclin D1 plays a pivotal role in transition from G1
to S phase and cyclin D1 expression pattern is associated
tumor characteristics and survival (Bova et al. 1999). As is
seen in human and other animal models (Niwa et al. 2001;
Yoshida et al. 2005) cyclin D1 expression showed an
increased expression in the oral squamous cell carcinoma
in our mice. E-cadherin, a calcium dependent membrane
protein that is essential for the formation of adherens
junction between cells. There is a connection with chang-
ing expression of E-cadherin and the transition from
hyperplasia to invasive carcinoma (Perl et al. 1998). We
observed less expression of E-cadherin in invasive section
of the carcinoma and evenly distributed expression in
earlier stages, a pattern that has been reported earlier in
human oral squamous cell carcinoma (Williams et al.
1998).
Average tumor volume advanced from 6 mm3 after
20 weeks to 30 mm3 at the 40 weeks time point. For intra-
tumor injection with an adenovirus it is desirable that the
size of each axe of the tumor is at least 2 mm, though
preferable higher. Eventual tumor size reduction after
treatment is then feasible. Assuming that the 4NQO oral
tumor model will not have the prospect to develop in to a
large tumor volume such as the model in which tumor cells
are injected subcutaneously in the flank, tumor volume will
not easily exceed 100 mm3. Previous experiments with
intra-tumor injection of gene therapy showed that the
injected volume must not surpass 30% of the volume of the
tumor (van der Eb et al. 2002). Taking this in to account
and knowing that the volume of an oral squamous cell
carcinoma in mice is small we estimate that a tumor vol-
ume of at least 15 mm3 is desirable. After 32 weeks the
tumor volume surpassed this point and after 40 weeks the
volume averaged 30 mm3. We estimate that a desirable
tumor volume will be reached after these 40 weeks and the
histopathology will reveal a squamous cell carcinoma,
without hampering the animal’s welfare.
The two most frequent used experimental procedures for
investigating therapies are in vitro cell lines and the nude
mouse. The 4NQO model has several advantages and dis-
advantages over these laboratory experiments. Compared
with the cell lines and the nude mouse model, the close
similarity of the 4NQO model to the physiological process
is a big benefit. The biggest drawback of the nude mouse
model is the lack of an immunocompetent component. The
weakness of the hamster cheek pouch model is the earlier
mentioned dissimilarity of the tumors with the human
equivalent. Application of DMBA causes an inflammatory
response and necrosis making it hard to study early squa-
mous lesions (Nauta et al. 1996). No inflammatory reaction
or necrosis was seen in our specimens. Other drawbacks of
this model are that the cheek pouch has no anatomic
counterpart in human, the epithelium of the cheek pouch is
significantly thinner than other parts of the oral mucosa of
humans and mice and the tumors seem to progress from
papillomas (MacDonald 1981; Nauta et al. 1995), which is
uncommon in humans and was not seen in our samples.
The clear disadvantage of the 4NQO model is that both the
cell line and the nude mouse are less time consuming and
that cell line experiments are less costly and most of the
time readily available.
In our conclusion taking both advantages and disad-
vantages in to account the 4NQO oral tumor model has
clear benefits and seems suitable for therapeutic research
applications.
Fig. 4 Volume of established tumors. Tumors were measured in
three dimensions and the volume was calibrated in mm3. The volumes
and ranges of each time point after the start of the treatment are
shown
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